Clinical Trial of PCSK9 Inhibitor and Statin Treatment for Carotid Artery Stenosis

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

406

Participants

Timeline

Start Date

July 30, 2025

Primary Completion Date

June 1, 2026

Study Completion Date

March 1, 2027

Conditions

Carotid Artery Stenosis

Interventions

DRUG

Evolocumab (biweekly injections) + Rosuvastatin/Atorvastatin ± Ezetimibe

PCSK9 inhibitor (biweekly injections) + rosuvastatin/atorvastatin ± ezetimibe

DRUG

Rosuvastatin/Atorvastatin ± Ezetimibe

Rosuvastatin/atorvastatin ± ezetimibe

All Listed Sponsors

collaborator

The First Affiliated Hospital of Soochow University

OTHER

lead

Changhai Hospital

OTHER